FOS and renal cell carcinoma: Herein, we found that RASAL2 interacted with GSK3β and then activated GSK3β through the reduction of Ser9 phosphorylation, and it ultimately reduced the expression of VEGFA in RCC, in which the nuclear oncogene c-FOS acted as an important bridge.